Memantine Hydrochloride Tablet
Product Images NDC 71335-1899

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Memantine Hydrochloride (NDC 71335-1899). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Memantine-figure1 (Memantine Figure1)

Memantine-figure1 (Memantine Figure1)
The text is describing a graph or chart showing the mean change from baseline in ADCS-ADL score over 12 weeks of treatment with either a placebo or memantine hydrachloride. It appears that there may be improvement with memantine hydrachloride and a decline with placebo, based on the "Clinical Degline" notation. SEM is used to represent standard error of mean.*
FDA Label Image

Memantine-figure3 (Memantine Figure3)

FDA Label Image

Memantine-figure5 (Memantine Figure5)

Memantine-figure5 (Memantine Figure5)
This is a report of a study that measured the change in ADCS-ADL score over several weeks of treatment with a combination of placebo and Donepezil or Memantine Hydrochloride and Donepezil. The mean change from baseline is graphically represented on a chart.*
FDA Label Image

Memantine-figure7 (Memantine Figure7)

Memantine-figure7 (Memantine Figure7)
The text represents a graph showing the mean change from baseline in SIB score for different treatments over a period of weeks. The treatments compared are Placebo/Donepezil, Memantine Hydrochloride, and Donepezil. The data is presented in the form of line graphs which shows the fluctuations of the mean score over weeks of treatment.*
FDA Label Image

Memantine_structure (Memantine Structure)

FDA Label Image

Label (Lbl713351899)

Label (Lbl713351899)
This appears to be a label or packaging information for a medication called "Namenda 10mg Tablet" by Ajanta Pharma Limited. It contains information about the quantity, expiration date, and storage instructions of the medication. The package was prepared by Bryant Ranck Prepack. It also includes a warning to keep drugs out of reach of children.*
FDA Label Image

Memantine-figure2 (Memantine Figure2)

FDA Label Image

Memantine-figure4 (Memantine Figure4)

FDA Label Image

Memantine-figure6 (Memantine Figure6)

FDA Label Image

Memantine-figure8 (Memantine Figure8)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.